|
|
.
NPI Detail
NPI: 1922103357
Type: Organization
Taxonomy Code: 261QP2000X
Clinic or Group Practice
Ambulatory Health Care Facilities/Clinic/Center, Physical Therapy
133 XXX XXXX XX 9 XXXX XXX
CONCORD, MA 017424159
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1922103357*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX
|
| 97110
|
THERAPEUTIC EXERCISES
|
XXXXX
|
$XXXXXX.X
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXX.XX
|
| 97140
|
MANUAL THERAPY 1/> REGIONS
|
XXXX
|
$XXXXXX.XX
|
| 84443
|
ASSAY THYROID STIM HORMONE
|
XXXX
|
$XXXXX.XX
|
| 80061
|
LIPID PANEL
|
XXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXXX.XX
|
| J1453
|
Fosaprepitant injection
|
XXXXX
|
$XXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J8540
|
Oral dexamethasone
|
XXXXX
|
-
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
| J1071
|
Inj testosterone cypionate
|
XXXXX
|
-
|
| J3262
|
Tocilizumab injection
|
XXXXX
|
$XXXXX.XX
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J3490
|
Drugs unclassified injection
|
XXXXX
|
-
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J3380
|
Injection, vedolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXX
|
$XXXXX.XX
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXX
|
$XXXXXX.XX
|
| J9047
|
Injection, carfilzomib, 1 mg
|
XXXX
|
$XXXXXX.XX
|
| J9349
|
Inj., tafasitamab-cxix
|
XXXX
|
$XXXXX.XX
|
| J2795
|
Ropivacaine hcl injection
|
XXXX
|
-
|
| J9264
|
Paclitaxel protein bound
|
XXXX
|
$XXXXX.XX
|
| J9171
|
Docetaxel injection
|
XXXX
|
-
|
| J9299
|
Injection, nivolumab
|
XXXX
|
$XXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
| G0463
|
Hospital outpt clinic visit
|
XXXX
|
$XXXXXX.XX
|
| U0004
|
Cov-19 test non-cdc hgh thru
|
XXXX
|
$XXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
